VOYAGER THERAPEUTICS INC. - COMMON STOCK

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

16 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

26 3 2024 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

13 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

28 2 2024 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

26 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

21 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research

20 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference

07 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Pricing of Public Offering

04 1 2024 22:45:43 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Proposed Public Offering

04 1 2024 16:14:15 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies

02 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program

06 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results

06 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

30 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference

25 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 9 2023 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics to Participate in Upcoming Investor Conferences

30 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer

07 8 2023 08:00:00 提供 Nasdaq GlobeNewswire